Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses - Other (Details)

v3.6.0.2
Acquisitions, Investments, and Licenses - Other (Details) - USD ($)
$ in Millions
1 Months Ended
Jan. 05, 2016
Mar. 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Business Acquisition [Line Items]        
Stock exchange agreement, stock received $ 5.0      
Stock exchange agreement, stock transferred $ 5.0      
Stock exchange agreement, stock transferred (in shares) 494,462      
Stock exchange agreement, stock received (in shares) 10,204,082      
Stock exchange agreement, calculated average stock price, consecutive trading days 10 days      
Common Stock, shares issued (in shares)     558,576,051 546,188,516
Xenetic Biosciences, Inc.        
Business Acquisition [Line Items]        
Stock exchange agreement, calculated average stock price, consecutive trading days 10 days      
Relative Core        
Business Acquisition [Line Items]        
Interest rate of notes payable   10.00%    
Relative Core        
Business Acquisition [Line Items]        
Origination of notes receivable from related parties   $ 5.0    
Notes receivable, related parties   $ 5.0    
Securities Pledged as Collateral        
Business Acquisition [Line Items]        
Common Stock, shares issued (in shares)   494,462    
Securities Pledged as Collateral | Xenetic Biosciences, Inc.        
Business Acquisition [Line Items]        
Common Stock, shares issued (in shares)   4,000,000